Avian flu vaccine

RFK Jr.’s Vaccine Panel Votes Against Flu Shot Preservative: No Surprise

A federal vaccine panel has controversially recommended against seasonal influenza vaccines containing thimerosal, a preservative used in some multi-dose vials. This decision, made after Health Secretary Robert F. Kennedy Jr. replaced the panel with members aligned with his anti-vaccine stance, may impact future vaccine availability. Despite a lack of scientific evidence of harm, the panel voted to restrict thimerosal, which is more cost-effective than single-dose formulations, potentially affecting clinics that rely on them. Multiple medical organizations have criticized the move, citing the settled science on thimerosal’s safety, and expressing concern about its global implications.

Read More

Record Child Flu Deaths Highlight Vaccination Drop

This flu season has witnessed a tragically high number of pediatric deaths, surpassing all years since the 2009 H1N1 pandemic with 216 fatalities reported thus far. This alarming figure is likely an undercount, with the final tally expected to rise further. A significant contributing factor is the decreased flu vaccination rate among children, falling from 64% five years ago to 49% this season. While the season has been severe overall, impacting millions with illness and thousands with death, indicators suggest a decline in flu activity since February.

Read More

FDA Cancels Flu Vaccine Meeting: Public Health Crisis Looms

User feedback revealed significant issues with the video ad experience. Problems reported included slow loading times, failure to load content, freezing, and excessively loud audio. Additionally, some users experienced ads that failed to start or complete. These issues collectively indicate a need for immediate technical improvements. Addressing these problems will improve user satisfaction and ad effectiveness.

Read More

RFK Jr. Cancels Vaccine Meeting, Sparking Health Fears

Following Robert F. Kennedy Jr.’s appointment, the CDC indefinitely postponed a vaccine advisory committee meeting and discontinued its “Wild to Mild” flu vaccine campaign. The campaign’s removal, amidst a severe flu season, occurred after the Department of Health and Human Services instructed the CDC to emphasize “informed consent” in vaccine messaging. Experts warn that overemphasizing potential vaccine risks, however minimal, could discourage vaccination uptake. This shift in messaging raises concerns about public health efforts to promote vital preventative healthcare.

Read More

Trump Admin Ends CDC Flu Vaccine Campaign Amidst Severe Outbreak

The Trump administration abruptly halted the CDC’s successful “Wild to Mild” flu vaccination campaign, which used animal imagery to illustrate the vaccine’s effectiveness in reducing illness severity. The decision, made by the Department of Health and Human Services under Robert F. Kennedy Jr.’s leadership, comes despite the campaign’s proven success in improving public understanding of flu vaccines and amidst a severe flu season with record-high hospitalizations. The campaign’s digital presence has been removed, and further communication efforts are now suspended. This action has prompted concern among public health experts given the campaign’s positive impact on vaccination rates, particularly among high-risk groups.

Read More

Conditional Approval for Avian Flu Vaccine Sparks Debate

The USDA conditionally licensed Zoetis’ avian flu vaccine for chickens, aiming to combat the devastating outbreak impacting egg prices. This conditional license, granted due to the vaccine’s demonstrated safety and efficacy, offers a potential solution to the ongoing crisis. While the US historically prioritized eradication through culling, the vaccine’s approval signals a potential shift in strategy, given the virus’s increasing spread and severity. The high cost of eggs is expected to persist into 2025, driven by the outbreak and broader inflation.

Read More